Compare JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Nasdaq Equity Premium Income ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? JPMorgan Nasdaq Equity Premium Income ETF trades at $61.07 (market cap $44.49B), while Roivant Sciences Ltd. Common Shares trades at $35.1 (market cap $24.72B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is the larger of the two by market cap, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Nasdaq Equity Premium Income ETF for 65 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| JEPQ | ROIV | |
|---|---|---|
Market Cap | $44.49B | $24.72B |
Volume | 5,681,789 | 6,279,442 |
Sector | Income / Options Overlay | Health |
52-Week High | $61.46 | $41.81 |
52-Week Low | $53.77 | $16.04 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | — | $20.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JEPQ trades at $61.03, down 0.39% on the day, with a bullish technical signal from moving averages despite neutral oscillators. The ETF maintains strong income generation through its covered-call strategy, with recent dividends ranging from $0.57 to $0.70 per share. Financial media coverage highlights JEPQ's 11% estimated annualized yield and suitability for retirement income, though analysts note the trade-off between high current income and limited price appreciation potential.
JEPQ offers exceptional current income for investors seeking monthly cash flow, with its covered-call strategy performing well in volatile markets. However, the ETF faces risks from market volatility dependence and potential principal erosion if yield chasing outweighs total return considerations. Institutional interest remains strong, with Envestnet increasing its position by 8.2% recently.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
